Michael T. Werner, Luke D. Powers, Judd H. Fastenberg
{"title":"Orbital preservation in the treatment of acute invasive fungal sinusitis","authors":"Michael T. Werner, Luke D. Powers, Judd H. Fastenberg","doi":"10.1016/j.amjoto.2024.104466","DOIUrl":null,"url":null,"abstract":"<div><p>Acute invasive fungal sinusitis (AIFS) is an aggressive disease with significant mortality and morbidity. Surgical debridement is a mainstay of treatment. However, orbital involvement may limit its efficacy and is an independent risk factor for mortality. Traditionally, orbital exenteration has been utilized in cases with orbital invasion and ophthalmoplegia or vision loss. Retrobulbar liposomal amphotericin B injection may improve disease control and has the potential to spare the morbidity associated with exenteration. In this video article, we document the use of serial endonasal debridement with retrobulbar injections to salvage the eye in a patient with significant orbital involvement. A 28-year-old immunocompromised female patient presented with acute onset restricted right extraocular movement, progressive orbital pain, V2 trigeminal numbness, and 20/40 vision. The patient underwent recurrent debridement and retrobulbar injections of liposomal amphotericin B. Her serial exams, including changes in extraocular muscle appearance and gradual improvement in extraocular movement, were documented. The exam six months after initial presentation demonstrated 20/20 vision, minimal extraocular movement restriction, and proper healing of the orbit and ethmoid. The salvage of the patient's orbit suggests that liposomal amphotericin B injections with debridement may be a viable treatment alternative in patients with acute invasive fungal sinusitis and orbital involvement.</p></div>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"45 6","pages":"Article 104466"},"PeriodicalIF":1.8000,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Otolaryngology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0196070924002527","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Acute invasive fungal sinusitis (AIFS) is an aggressive disease with significant mortality and morbidity. Surgical debridement is a mainstay of treatment. However, orbital involvement may limit its efficacy and is an independent risk factor for mortality. Traditionally, orbital exenteration has been utilized in cases with orbital invasion and ophthalmoplegia or vision loss. Retrobulbar liposomal amphotericin B injection may improve disease control and has the potential to spare the morbidity associated with exenteration. In this video article, we document the use of serial endonasal debridement with retrobulbar injections to salvage the eye in a patient with significant orbital involvement. A 28-year-old immunocompromised female patient presented with acute onset restricted right extraocular movement, progressive orbital pain, V2 trigeminal numbness, and 20/40 vision. The patient underwent recurrent debridement and retrobulbar injections of liposomal amphotericin B. Her serial exams, including changes in extraocular muscle appearance and gradual improvement in extraocular movement, were documented. The exam six months after initial presentation demonstrated 20/20 vision, minimal extraocular movement restriction, and proper healing of the orbit and ethmoid. The salvage of the patient's orbit suggests that liposomal amphotericin B injections with debridement may be a viable treatment alternative in patients with acute invasive fungal sinusitis and orbital involvement.
急性侵袭性真菌性鼻窦炎(AIFS)是一种侵袭性疾病,死亡率和发病率都很高。手术清创是治疗的主要方法。然而,眼眶受累可能会限制其疗效,并且是导致死亡的一个独立风险因素。传统上,眶外扩张术适用于眶部受侵、眼球震颤或视力丧失的病例。眼底脂质体两性霉素 B 注射可提高疾病控制率,并有可能避免与开颅手术相关的发病率。在这篇视频文章中,我们记录了一名眼眶严重受累的患者通过连续鼻内清创和球后注射挽救眼球的过程。一名 28 岁的免疫功能低下女性患者因急性发病而出现右眼眼外肌活动受限、进行性眼眶疼痛、V2 三叉神经麻木和 20/40 视力。患者接受了反复的清创术和球后注射两性霉素 B 脂质体。初次就诊六个月后的检查结果显示,患者的视力达到了 20/20,眼外肌活动受限程度极小,眼眶和蝶窦适当愈合。患者眼眶的修复表明,对于急性侵袭性真菌性鼻窦炎和眼眶受累的患者来说,注射两性霉素 B 脂质体并进行清创可能是一种可行的替代治疗方法。
期刊介绍:
Be fully informed about developments in otology, neurotology, audiology, rhinology, allergy, laryngology, speech science, bronchoesophagology, facial plastic surgery, and head and neck surgery. Featured sections include original contributions, grand rounds, current reviews, case reports and socioeconomics.